| 1 |
Development of a First-in-Class Nanodrug (DC-MT) Candidate for Colorectal Cancer Radiotherapy |
| Others-Synth. |
Concurrent Chemoradiotherapy for solid tumor |
Hypoxic tumor microenvironment cancer |
Candidate |
Dr.Cure.,Co.,LTD. |
RS-2026-25503777 |
|
| 2 |
Preclinical study for the development of MRI contrast agent of innovative artificial melanin |
| Others-Synth. |
Diagnostic |
Liver, Kidney |
Preclinical |
BL Melanis |
RS-2022-00165594 |
|
| 3 |
Tumor Targeting Liposomal Formulation of Cathepsin B-specific Doxorubicin Prodrug for Drug Resistant Cancer Treatment |
| Others-Synth. |
Colerectal cancer, Breast cancer, Ovarian cancer, Pancreatic cancer |
Cathepsin B |
Lead |
Ewha Womans University |
HN21C0349 |
|